ALZHEIMER’S DISEASE
JULY 27–31, 2020
The Early Diagnosis of Alzheimer’s: Readying the Health System
At the Alzheimer’s Association International Conference 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease, including the role of clinical assessment tools and biomarkers, alongside the effect of the Covid-19 pandemic.
ALZHEIMER’S DISEASE
MAY 24, 2020
The Early Diagnosis of Alzheimer’s: Delineating the Cause of Memory Impairment
At the virtual 6th Congress of the European Academy of Neurology 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease (AD) and healthcare system readiness to facilitate this.
ALZHEIMER’S DISEASE
MARCH 29, 2019
The Early Diagnosis of Alzheimer’s: Exploring Pathological Obstacles
At the International Conference on Alzheimer’s and Parkinson’s Disease 2019, an expert panel discussed the clinical presentation of Alzheimer’s disease (AD) in the early stages and outlined the role of cognitive assessment tools and biomarkers in supporting an early diagnosis.
ALZHEIMER’S DISEASE
JULY 23, 2018
The Early Diagnosis of Alzheimer’s: Exploring a Patient with Memory Complaints and Identifying Underlying Pathologies
At the Alzheimer’s Association International Conference 2018, an expert panel discussed the importance of an early diagnosis of Alzheimer’s disease (AD).
STROKE
February 6, 2019
Understanding Severe Stroke Recognition & Management
At the 2019 International Stroke Conference, Biogen collaborated with a panel of experts to outline and discuss key considerations for the recognition and treatment of large hemispheric infarction (LHI).
PSP
September 23, 2019
Differentiating PSP
At the 2019 International Congress of Parkinson’s Disease and Movement Disorders, an expert panel discussed the early clinical presentation of progressive supranuclear palsy (PSP), the differentiation of PSP from Parkinson’s disease, and the burden of disease.